Related Experiment Video
Updated: Sep 5, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Refractory Mycoplasma Pneumonia in Children: A Systematic Review and Meta-analysis of Laboratory Features and
Wanjie Huang1, Xianhong Xu1, Wenqi Zhao1
1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Background:
Mycoplasma pneumoniae is a common pathogen of community-acquired pneumonia (CAP) in children. M. pneumoniae infection is usually regarded as a self-limiting disease, but in some special cases, it can also develop into refractory Mycoplasma pneumoniae pneumonia (RMPP). The aim of this study is to analyze the clinical characteristics of CRP (C-reactive protein), LDH (lactate dehydrogenase), ESR (erythrocyte sedimentation rate), D-dimer, neutrophils (%), lymphocytes (%), and lung consolidation in RMPP and explore their prediction results in the early stage of RMPP, which is important for early treatment.
Methods:
This systematic search was conducted in PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wangfang, and Cqvip, and the date was set until February 23, 2021. For the continuous variables, mean difference (MD) with 95% CI was adopted to evaluate CRP, LDH, ESR, D-dimer, neutrophils (%), lymphocytes (%), and the correlation between lung consolidation and RMPP.
Results:
20 studies including 5289 patients were included in the analysis, and the results showed that the CRP of the RMPP group (MD (95% CI): 22.29 (12.20, 32.38), P < 0.001), LDH (MD (95% CI): 145.13 (78.62, 211.64), P < 0.001), neutrophils (%) (MD (95% CI): 7.27 (0.31, 14.23), P = 0.04), and D-dimer (MD (95% CI): 1.79 (-1.17, 4.74), P = 0.24) was higher than that of the NRMPP group; the risk of lung consolidation in the RMPP group (OR (95% CI): 14.29 (4.52, 45.12), P < 0.001) was higher than that in the NRMPP group, and there was no difference in ESR (MD (95% CI): 8.11 (-1.34, 17.56), P = 0.09) and lymphocytes (%) (MD (95% CI): -6.27 (-12.81, 0.27), P = 0.06) between the two groups.
Conclusion:
So, the available evidence indicates that CRP, LDH, neutrophils (%), D-dimer, and lung consolidation are predictive factors for RMPP.
Insights
Refractory Mycoplasma pneumoniae pneumonia (RMPP) in children can be predicted by elevated C-reactive protein (CRP), lactate dehydrogenase (LDH), neutrophils, and lung consolidation. Early identification of these biomarkers aids in timely RMPP treatment.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- Mycoplasma pneumoniae is a frequent cause of community-acquired pneumonia (CAP) in children.
- While typically self-limiting, M. pneumoniae infections can progress to refractory pneumonia (RMPP).
- Early identification of RMPP is crucial for effective treatment.
Purpose of the Study:
- To analyze clinical characteristics of C-reactive protein (CRP), lactate dehydrogenase (LDH), erythrocyte sedimentation rate (ESR), D-dimer, neutrophils, lymphocytes, and lung consolidation in RMPP.
- To explore the predictive value of these markers in the early stages of RMPP.
Main Methods:
- A systematic literature search was conducted across multiple databases (PubMed, Embase, Web of Science, etc.) up to February 23, 2021.
- Meta-analysis was performed using mean difference (MD) with 95% confidence intervals (CI) for continuous variables.
- Odds ratios (OR) with 95% CI were used to evaluate the correlation between lung consolidation and RMPP.
Main Results:
- Elevated CRP, LDH, neutrophils, and increased risk of lung consolidation were observed in RMPP patients compared to non-RMPP cases.
- D-dimer showed a non-significant trend towards elevation in RMPP.
- No significant differences in ESR or lymphocyte percentages were found between RMPP and non-RMPP groups.
Conclusions:
- CRP, LDH, neutrophils, and lung consolidation are identified as significant predictive factors for RMPP in children.
- These biomarkers can aid in the early diagnosis and management of refractory Mycoplasma pneumoniae pneumonia.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....